ASP Isotopes Inc. to Post FY2025 Earnings of ($0.07) Per Share, HC Wainwright Forecasts (NASDAQ:ASPI)

ASP Isotopes Inc. (NASDAQ:ASPI) – Equities researchers at HC Wainwright issued their FY2025 earnings per share estimates for shares of ASP Isotopes in a research report issued on Wednesday, April 17th. HC Wainwright analyst H. Ihle forecasts that the company will earn ($0.07) per share for the year. HC Wainwright currently has a “Buy” rating and a $5.50 target price on the stock. The consensus estimate for ASP Isotopes’ current full-year earnings is $0.07 per share.

ASP Isotopes Price Performance

ASPI opened at $3.10 on Thursday. The stock’s 50-day moving average price is $3.67 and its 200 day moving average price is $2.40. ASP Isotopes has a 12-month low of $0.28 and a 12-month high of $4.97. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.01. The firm has a market cap of $151.65 million, a price-to-earnings ratio of -6.33 and a beta of 5.03.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in ASP Isotopes by 761.7% during the 4th quarter. Vanguard Group Inc. now owns 176,314 shares of the company’s stock worth $316,000 after buying an additional 155,853 shares during the last quarter. Virtu Financial LLC purchased a new position in ASP Isotopes during the 4th quarter worth approximately $26,000. GSA Capital Partners LLP purchased a new position in ASP Isotopes during the 4th quarter worth approximately $608,000. Citadel Advisors LLC purchased a new position in ASP Isotopes during the 4th quarter worth approximately $187,000. Finally, Rathbones Group PLC purchased a new position in ASP Isotopes during the 4th quarter worth approximately $272,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

Insider Buying and Selling at ASP Isotopes

In related news, Director Robert John Andrew Ryan purchased 15,596 shares of ASP Isotopes stock in a transaction on Monday, January 29th. The shares were bought at an average price of $2.35 per share, with a total value of $36,650.60. Following the transaction, the director now directly owns 537,055 shares of the company’s stock, valued at $1,262,079.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 26.30% of the stock is owned by corporate insiders.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.